Abbvie Inc [ABBV] stock is trading at $204.08, up 0.99%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The ABBV shares have gain 5.81% over the last week, with a monthly amount glided 19.58%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Previously, Daiwa Securities downgraded its rating to Neutral on December 05, 2024, and kept the price target unchanged to $180. On November 22, 2024, upgrade upgraded it’s rating to Outperform but maintained its price target of $206 on the stock. Wolfe Research started tracking the stock assigning a Outperform rating and suggested a price target of $205 on November 15, 2024. Argus upgraded its rating to a Buy. Bernstein started tracking with a Mkt Perform rating for this stock on October 17, 2024, and assigned it a price target of $203. In a note dated June 05, 2024, HSBC Securities upgraded an Buy rating on this stock but restated the target price of $185.
Abbvie Inc [ABBV] stock has fluctuated between $153.58 and $207.32 over the past year. Currently, Wall Street analysts expect the stock to reach $214.8 within the next 12 months. Abbvie Inc [NYSE: ABBV] shares were valued at $204.08 at the most recent close of the market. An investor can expect a potential return of 5.25% based on the average ABBV price forecast.
Analyzing the ABBV fundamentals
Abbvie Inc [NYSE:ABBV] reported sales of 56.33B for the trailing twelve months, which represents a growth of 5.60%. Gross Profit Margin for this corporation currently stands at 0.74% with Operating Profit Margin at 0.16%, Pretax Profit Margin comes in at 0.07%, and Net Profit Margin reading is 0.08%. To continue investigating profitability, this company’s Return on Assets is posted at 0.03, Equity is 0.71 and Total Capital is 0.09. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of20.19.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 201.74 points at the first support level, and at 199.40 for the second support level. However, for the 1st resistance point, the stock is sitting at 205.96, and for the 2nd resistance point, it is at 207.84.
Ratios To Look Out For
For context, Abbvie Inc’s Current Ratio is 0.66. Further, the Quick Ratio stands at 0.55, while the Cash Ratio is 0.14. Considering the valuation of this stock, the price to sales ratio is 6.40, the price to book ratio is 108.35 and price to earnings (TTM) ratio is 85.33.
Transactions by insiders
Recent insider trading involved Siatis Perry C, EVP, GC AND SECRETARY, that happened on Feb 20 ’25 when 5778.0 shares were sold. Officer, PERRY C SIATIS completed a deal on Feb 20 ’25 to buy 5778.0 shares. Meanwhile, SVP, CONTROLLER Buckbee Kevin K sold 1800.0 shares on Dec 16 ’24.
